- Home
- CRMD vs BALY Comparison
CRMD vs BALY Comparison
Compare CRMD & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRMD | BALY |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | 191 | 11700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.9M | 731.8M |
| IPO Year | 2009 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CRMD | BALY |
|---|---|---|
| Price | $8.77 | $12.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $14.83 | $12.40 |
| AVG Volume (30 Days) | ★ 1.5M | 60.9K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | 8.37 |
| EPS | ★ 0.43 | N/A |
| Revenue | $311,709,000.00 | ★ $2,436,189,000.00 |
| Revenue This Year | $0.30 | $21.50 |
| Revenue Next Year | N/A | $5.45 |
| P/E Ratio | $20.44 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $6.13 | $8.79 |
| 52 Week High | $14.96 | $20.74 |
Technical Indicators
Market Signals| Indicator | CRMD | BALY |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 41.66 |
| Support Level | $8.09 | $12.43 |
| Resistance Level | $9.03 | $14.76 |
| Average True Range (ATR) | 0.39 | 1.14 |
| MACD | 0.02 | -0.22 |
| Stochastic Oscillator | 84.34 | 3.19 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.